Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial

Zhang, XY; Ren, HH; Zhao, CL; Shi, Z; Qiu, L; Yang, FM; Zhou, XH; Han, XY; Wu, K; Zhong, HZ; Li, YF; Li, JH; Ji, LN

Ji, LN (通讯作者),Peking Univ, Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Diabet Ctr, Beijing, Peoples R China.;Zhong, HZ; Li, JH (通讯作者),BGI Shenzhen, Shenzhen, Peoples R China.;Li, YF (通讯作者),Capital Med Univ, Dept Endocrinol, Beijing Friendship Hosp, Pinggu Campus, Beijing, Peoples R China.;Li, JH (通讯作者),BGI Shenzhen, Shenzhen Key Lab Unknown Pathogen Identificat, Shenzhen, Peoples R China.

DIABETOLOGIA, 2022; 65 (10): 1613

Abstract

Aims/hypothesis The use of oral glucose-lowering drugs, particularly those designed to target the gut ecosystem, is often observed in association with......

Full Text Link